Xeris Biopharma XERS Q1 2026 Earnings Surprise Profitability as EPS Beats Estimates PAC Q1 2026 Earnings Strong EPS Beat Fails to Lift Stock Amid Cautious Sentiment NFG Q1 2026 Earnings EPS Misses Estimates as Stock Edges Lower CVNA Q1 2026 Earnings EPS Beats Estimates by Over 12 Stock Surges 6 ERII Q1 2026 Earnings EPS Miss Highlights Ongoing Cost Pressures Despite Stock Gain BCYC Q1 2026 Earnings WiderThanExpected Loss But Shares Edge Higher